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Abstract
Background: We evaluated the effectiveness of a policy allowing for the sale of over-the-counter drugs outside of
pharmacies by examining its effect on number of monthly outpatient visits for acute upper respiratory infections,
dyspepsia, and migraine.
Method: We used medical claims data extracted from the Korean National Health Insurance Cohort Database from
2009 to 2013. The Korean National Health Insurance Cohort Database comprises a nationally representative sample
of claims - about 2% of the entire population - obtained from the medical record data held by the Korean National
Health Insurance Corporation (which has data on the entire nation). The analysis included26,284,706 person-months
of 1,042,728 individuals. An interrupted-time series analysis was performed. Outcome measures were monthly
outpatient visits for acute upper respiratory infections, dyspepsia, and migraine. To investigate the effect of the
policy, we compared the number of monthly visits before and after the policy’s implementation in 2012.
Result: For acute upper respiratory infections, monthly outpatient visits showed a decreasing trend before the
policy (ß = −0.0003);after it, a prompt change and increasing trend in monthly outpatient visits were observed, but
these were non-significant. For dyspepsia, the trend was increasing before implementation (ß = −0.0101), but this
reversed after implementation(ß = −0.007). For migraine, an increasing trend was observed before the policy (ß = 0.
0057). After it, we observed a significant prompt change (ß = −0.0314) but no significant trend.
Conclusion: Deregulation of selling over-the-counter medication outside of pharmacies reduced monthly
outpatient visits for dyspepsia and migraine symptoms, but not acute upper respiratory infections.
Keywords: Pharmacy, Policy, Korea, Nonprescription drugs, Outpatients
Background
Before November 2012, it was forbidden in the Republic
of Korea to sell medicine or medical supplies in places
other than pharmacies. This included both prescribed
pharmaceuticals and over-the-counter drugs. However,
this meant that many people were unable to buy necessary
or desired medication at night or during holidays, when
pharmacies are closed. The social need for greater access
to this medication eventually became too great to ignore,
prompting the government to address the issue. As a
result, in November 2012, the government implemented
an over-the-counter drug policy that permitted the sale of
over-the-counter drugs such as cold and digestive medi-
cines, antipyretics, analgesics, and pain relief patches in
places outside of the pharmacy [1].
In the United States of America, the United Kingdom,
Germany, and numerous countries, over-the-counter drugs
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are legally sold in convenience stores and supermarkets
[2]. As such, there have been many previous studies
focusing on the myriad impacts of these drugs. For
instance, Smith and Feldman performed a systematic
review of clinical trials of over-the-counter drugs, and
found that some over-the-counter drugs, whether on
their own or in combination, have positive effects on
reducing cold symptoms(i.e., upper respiratory tract
infections)in adolescents and adults [3]. In contrast,
Schroederand Fahey suggested that over-the-counter
cough medicines were ineffective for reducing acute
cough in adults [4]. Other than investigating the effect-
iveness of over-the-counter medications themselves,
many studies have focused on the side effects of these
drugs, which remain a major concern [5, 6]. Furthermore,
children’s caregivers may lack sufficient knowledge of the
appropriate dosages or types of over-the-counter drugs to
utilize them safely [7], and many studies, including more
recent ones, have reported notable rates of drug abuse
and adverse effects related to using over-the-counter
medications [8–11].
Despite the plethora of information on over-the-counter
drugs, the actual effects of over-the-counter drug policies
on the population remain unknown. Specifically, it re-
mains unclear whether being able to access over-the-
counter drugs at places outside the pharmacy has reduced
medical service use and the number of outpatients for
conditions such as acute upper respiratory infections; this
effect is particularly difficult to evaluate because the
sale of over-the-counter drugs at places outside the
pharmacy has already been unregulated long ago in
many countries [12].
Given this lack of information on the effectiveness of
over-the-counter drug policies, we sought to evaluate the
effectiveness of the policy implemented in the Republic of
Korea in 2012 for reducing the number of outpatient visits
for acute upper respiratory infections, dyspepsia, and
migraine by comparing these numbers before and after its
implementation.
Methods
We used medical claims data extracted from the Korean
National Health Insurance Cohort Database from 2009
to 2013. The Korean National Health Insurance Cohort
Database comprises a nationally representative sample of
claims—about 2% of the entire population—obtained
from the medical record data held by the Korean
National Health Insurance Corporation (which has data
on the entire nation) [13]. The specific data used in-
cluded details of each patient’s utilization of healthcare.
We handled each patient’s medical record data by month in
order to analyze patients’ trends over time. Overall, the ana-
lysis included 26,284,706 person-months from 1,042,728
individuals. This study was approved by the institutional
review board at Yonsei University Graduate School of
Public Health (2014–239). Because patients’ information
was anonymized before the analysis, we did not require the
informed consent of participants.
Design
We used an interrupted time-series analysis to evalu-
ate the trends over time in monthly outpatient visits
in the Republic of Korea for the above three condi-
tions [14–16]. Interrupted time-series is appropriate
for investigation of intervention and it’s longitudinal
effects over time. Our data composed by a series of
measurements over time interrupted by an intervention.
We performed segmented linear regression model with
individual-level data which includes segments of pre-
intervention and post-intervention [17, 18].
Yt ¼ β0 þ β1  Timet þ β2  Interventiont
þβ3  Time after interventiont
þβ4  Covariatest þ et
Our main intervention is implementation of the policy
permitting the sale of over-the-counter drug sat places
outside the pharmacy.
Outcome measures
Over-the-counter drug policy that permitted the sale of
over-the-counter drugs was mainly about cold and di-
gestive medicines, antipyretics. Therefore, outcome
measures included the number of outpatient visits per
month for complaints of acute upper respiratory infec-
tions, dyspepsia, and migraine which is target disease of
permitted drugs. The following codes from the Inter-
national Statistical Classification of Diseases and Related
Health Problems, 10th Revision, were used to identify
outpatient visits for these conditions: acute upper re-
spiratory infections (J00 to J06), dyspepsia(K30,F45.3,
and R12), and migraine(G43 and G44).
Independent variables
The intervention variable was the implementation of the
policy permitting the sale of over-the-counter drugs at
places outside the pharmacy. Thus, an “intervention” ef-
fect refers to a prompt change in the number of monthly
outpatient visits just after implementation of the over-
the-counter drug policy in November 2012. The “trend
before policy” refers to the trend in monthly outpatient
visits before the implementation of the over-the-counter
drug policy, while the “trend after policy” refers to the
trend in monthly outpatient visits after implementation
of the policy.
For covariates, we assessed the general characteristics
of sex, age (20–40 years, 40–60 years, 60–80 years, or
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>80 years), type of insurance (employee insurance, self-
employed insurance, or Medicaid), income (four quar-
tiles), region (urban or rural), and type of hospital
usually used for the outcome measure symptoms
(general hospital, hospital, clinic, or others). Further-
more, we included the Elixhauser comorbidity index as
a measure of medical condition. This index comprises
31 categories of comorbid diseases [19], and allowed us
to control for certain critical medical conditions that
would influence individuals’ well-being, such as peptic
ulcer disease, paralysis, peripheral vascular disorders,
valvular disease, neurological disorders and rheumatoid
arthritis/collagen disorders, metastatic cancer, obesity,
alcohol abuse, and drug abuse (see Additional file 1).
Statistical analysis
We aggregated patients’ medical records by month so that
each patient had a maximum of 48 repeated measures
(i.e., 4 years). We used t-tests to identify differences in the
mean number monthly outpatient visits by patients’ char-
acteristics. We used a generalized estimating equation
model to account for the longitudinal nature of the data
and thereby ensure an appropriate analysis. Furthermore,
we used an autoregressive covariance structure and a
negative binomial distribution to account for the inter-
rupted time series design and distribution of monthly
outpatient visits in our data [20, 21]. All analyses were
performed using the SAS software package (ver. 9.3; SAS
Institute, Inc., Cary, NC).
Results
Study participants’ general characteristics are listed in
Table 1. Of the 10,42,718patients, 49.8% were male and
39.24% were under 20 years old. Furthermore, 46.8% of
patients were living in urban areas. Most patients 59.5%
usually visited clinics for acute upper respiratory infec-
tions; 77% did so for dyspepsia and migraine.
Table 2 presents the mean monthly outpatient visits by
outcome measure. For acute upper respiratory infec-
tions, the mean number of monthly outpatient visits was
0.2742. Female and younger patients tended to have
more outpatient visits than did male and older ones, re-
spectively (Male: 0.2880; Female: 0.3137), (Less than 30:
0.4031; 30–39: 0.2895; 40–49: 0.2351; 50–59: 0.2125;
60–69: 0.2055; 70–79: 0.2049; more than 80: 0.1321). Pa-
tients who has high income tended to have more out-
patient visits than who has low income (1st Quartile:
0.2734; 2nd Quartile: 0.2858; 3rd Quartile: 0.3204; 4th
Quartile: 0.3068). Korea mainly have three types of
health insurance (Self-employed insured, employee in-
sured, Medicaid). Patients who have employee insured
tended to have more outpatient visits than patients who
have other insurance (Self-employed insured: 0.2881;em-
ployee insured: 0.3109; Medicaid: 0.2392).
For symptoms of dyspepsia, the mean number of
monthly outpatient visits was fewer than acute upper re-
spiratory infections, which was 0.0045. As with acute
upper respiratory infections, female patients tended to
have greater mean number of visits for dyspepsia, while
Table 1 Patients’ general characteristics
Number Percent
Sex
Male 518,793 49.8
Female 523,935 50.3
Age
less than 30 409,186 39.2
30–39 165,379 15.9
40–49 177,031 17.0
50–59 135,173 13.0
60–69 84,577 8.1
70–79 52,063 5.0
80 or more 19,319 1.9
Insurance
Self-employed insured 353,906 33.9
employee insured 655,998 62.9
Medicaid 32,824 3.2
Income
Q1(Low) 167,277 16.0
Q2 248,196 23.8
Q3 342,296 32.8
Q4(High) 284,959 27.3
Region
Urban 487,892 46.8
Rural 554,836 53.2
Type of hospital (Acute upper respiratory infection)
General hospital 100,539 9.6
Hospital 92,976 8.9
Clinic 620,058 59.5
Others 229,155 22.0
Type of hospital (Dyspepsia)
General hospital 107,329 10.3
Hospital 105,076 10.1
Clinic 803,233 77.0
Others 27,090 2.6
Type of hospital (Migraine)
General hospital 106,703 10.2
Hospital 104,797 10.1
Clinic 802,351 77.0
Others 28,877 2.8
Total 1,042,728 100
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patients who did not have a comorbid disease tended to
have a greater number of visits than did those who did
have a comorbid disease(Male: 0.0036; Female: 0.0041).
Older patients tended to have more outpatient visits
than did younger ones(Less than 30: 0.0038; 30–39:
0.0035; 40–49: 0.0035; 50–59: 0.0038; 60–69: 0.0042;
70–79: 0.0056; more than 80: 0.0047). Patients who
have Medicaid insurance tended to have more out-
patient visits than patients who have other insurance
(Self-employed insured: 0.0037; employee insured:
0.0039;Medicaid: 0.0041). For migraine, the mean num-
ber of monthly outpatient visits was0.0078. Older pa-
tients tended to have more outpatient visits than did
younger ones, patients who have Medicaid insurance
tended to have more outpatient visits than patients who
have other insurance (Less than 30: 0.0034; 30–39:
0.0069; 40–49: 0.0083; 50–59: 0.0078; 60–69: 0.0073;
70–79: 0.0104; more than 80: 0.0060), (Self-employed
insured: 0.0063; employee insured: 0.0058; Medicaid:
0.0094).
Table 3 presents the interrupted time-series analysis of
the effect of the over-the-counter medication policy.
Each number in Table 3 present change of monthly out-
patient visits for three separate symptoms. For acute
upper respiratory infections, we observed a significant
decreasing trend in monthly outpatient visits before the
policy implementation (ß = −0.0003). After implement-
ing the policy, we observed a prompt change in monthly
outpatient visits (ß = 0.0026) but this was not statisti-
cally significant. Similarly, the trend after the policy was
now increasing, but not to a significant degree. In
summary, the monthly outpatient visits for acute upper
Table 2 Mean number of monthly outpatient visits for acute upper respiratory infections, dyspepsia, and migraine
Acute upper respiratory infections Dyspepsia Migraine
Mean SD p-value Mean SD p-value Mean SD p-value
Sex
Male 0.2880 0.6873 <.0001 0.0036 0.0718 <.0001 0.0046 0.0814 <.0001
Female 0.3137 0.7211 0.0041 0.0781 0.0075 0.1102
Age
less than 30 0.4031 0.7902 <.0001 0.0038 0.0702 <.0001 0.0034 0.0659 <.0001
30–39 0.2895 0.6551 0.0035 0.0746 0.0069 0.1032
40–49 0.2351 0.6147 0.0035 0.0688 0.0083 0.1130
50–59 0.2125 0.6260 0.0038 0.0812 0.0078 0.1087
60–69 0.2055 0.6376 0.0042 0.0780 0.0073 0.1090
70–79 0.2049 0.6808 0.0056 0.0900 0.0104 0.1519
80 or more 0.1321 0.5058 0.0047 0.1179 0.0060 0.1021
Insurance
Self-employed insured 0.2881 0.6903 <.0001 0.0037 0.0729 0.0002 0.0063 0.0964 <.0001
employee insured 0.3109 0.7141 0.0039 0.0763 0.0058 0.0949
Medicaid 0.2392 0.6593 0.0041 0.0714 0.0094 0.1358
Income
Q1(Low) 0.2734 0.6754 <.0001 0.0037 0.0730 <.0001 0.0071 0.1058 <.0001
Q2 0.2858 0.6810 0.0039 0.0785 0.0059 0.0993
Q3 0.3204 0.7249 0.0039 0.0735 0.0054 0.0860
Q4(High) 0.3068 0.7160 0.0038 0.0749 0.0062 0.1019
Region
Urban 0.2993 0.7104 0.0007 0.0036 0.0735 <.0001 0.0061 0.1004 <.0001
Rural 0.3023 0.6995 0.0040 0.0763 0.0060 0.0939
Type of hospital
General hospital 0.1063 0.4213 <.0001 0.0031 0.0598 <.0001 0.0099 0.1058 <.0001
Hospital 0.1999 0.5582 0.0027 0.0551 0.0064 0.0931
Clinic 0.3375 0.7456 0.0044 0.0828 0.0054 0.0961
Others 0.3778 0.6915 0.0032 0.0655 0.0073 0.1020
Total 0.2742 0.7321 0.0045 0.0870 0.0078 0.1171
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Table 3 Interrupted time series analysis of the effect of the over-the-counter drug policy on number of monthly outpatient visits for
acute upper respiratory infections, dyspepsia, and migraine
Acute upper respiratory infections Dyspepsia Migraine
Estimation Standard error p-value Estimation Standard error p-value Estimation Standard error p-value
Trend −0.0003* 0.0001 <.0001 0.0101* 0.0005 <.0001 0.0057* 0.0003 <.0001
Intervention
Yes 0.0026 0.0017 0.1307 −0.0216 0.0194 0.2651 −0.0314* 0.0151 0.037
No Ref. - - Ref. - - Ref. - -
Trend after intervention 0.0002 0.0002 0.3416 −0.007* 0.0021 0.0007 0.0019 0.0016 0.2497
Sex
Male −0.0137* 0.0015 <.0001 −0.2174* 0.0144 <.0001 −0.4796* 0.0149 <.0001
Female Ref. - - Ref. - - Ref. - -
Age
less than 30 0.568* 0.0107 <.0001 1.2492* 0.0406 <.0001 1.0934* 0.0429 <.0001
30–39 0.4174* 0.0108 <.0001 1.1252* 0.0422 <.0001 1.4585* 0.0426 <.0001
40–49 0.3975* 0.0108 <.0001 0.8341* 0.0426 <.0001 1.344* 0.0427 <.0001
50–59 0.3842* 0.0109 <.0001 0.462* 0.0433 <.0001 1.0162* 0.0429 <.0001
60–69 0.3177* 0.0113 <.0001 0.0865* 0.0438 0.0484 0.5039* 0.0441 <.0001
70–79 0.1888* 0.0115 <.0001 −0.0287 0.0448 0.5216 0.1723* 0.0451 0.0001
80 or more Ref. - - Ref. - - Ref. - -
Insurance
Self-employed insured Ref. - - Ref. - - Ref. - -
employee insured 0.0004 0.0062 0.9423 0.0868* 0.0424 0.0406 0.1812* 0.0406 <.0001
Medicaid 0.0215* 0.0063 0.0006 0.1346* 0.0438 0.0021 0.1915* 0.042 <.0001
Income
Q1(Low) −0.0459* 0.0024 <.0001 −0.2681* 0.0225 <.0001 −0.1883* 0.0198 <.0001
Q2 −0.0407* 0.002 <.0001 −0.2768* 0.0183 <.0001 −0.2068* 0.017 <.0001
Q3 0.0047* 0.0016 0.0043 −0.185* 0.0167 <.0001 −0.1625* 0.0154 <.0001
Q4(High) Ref. - - Ref. - - Ref. - -
Region
Urban 0.0646* 0.0015 <.0001 0.5416* 0.0137 <.0001 0.5124* 0.013 <.0001
Rural Ref. - - Ref. - - Ref. - -
Type of hospital
General hospital −0.0509* 0.0071 <.0001 −0.0013* 0.0385 <.0001 −0.0149* 0.0275 <.0001
Hospital −0.0132* 0.0047 <.0001 −0.0062* 0.0284 <.0001 −0.058* 0.0208 <.0001
Clinic −0.002* 0.0044 <.0001 0.1791* 0.0245 <.0001 −0.0505* 0.0184 <.0001
Others Ref. - - Ref. - - Ref. - -
Admission in last month
Yes Ref. - - Ref. - - Ref. - -
No 0.0262* 0.0031 <.0001 −0.2025* 0.0257 <.0001 −0.1626* 0.0197 <.0001
Season
Spring 0.0113* 0.0009 <.0001 0.0046 0.0102 0.654 0.0762* 0.0075 <.0001
Summer −0.0801* 0.0011 <.0001 0.0147 0.011 0.181 0.136* 0.008 <.0001
Fall −0.0065* 0.0009 <.0001 −0.0495* 0.0106 <.0001 0.0512* 0.0076 <.0001
Winter Ref. - - Ref. - - Ref. - -
*: p-value < 0.05; All covariates are adjusted
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respiratory infections showed a decreasing trend before
the policy, and implementing the policy had no signifi-
cant effect.
For symptoms of dyspepsia, a significant increasing
trend before the policy was observed(ß = −0.0101).
While implementing the policy did not induce a signifi-
cant prompt reduction in monthly outpatient visits, the
decreasing trend after the policy was significant
(ß = −0.007). Thus, the over-the-counter drug policy
may have changed the trend in outpatient visits for
dyspepsia.
For migraine, the trend before the policy was increas-
ing (ß = 0.0057). After the policy implementation, we
observed a prompt decrease in monthly outpatient visits
(ß = −0.0314). However, there was no significant trend.
Tables 4 and 5 presents subgroup analysis of inter-
rupted time-series by income. Table 4 shows effect of
the over-the-counter medication policy on low-income
population, and Table 5 shows effect of the over-the-
counter medication policy on high-income population.
Total trend of the monthly outpatient visits in all symp-
toms were similar in both sub-population and statisti-
cally significant. In acute upper respiratory infections,
there were prompt increase in monthly outpatient visits
among low-income population after the intervention,
but trend after intervention was decreasing and it was
not statistically significant (Intervention: 0.0052; trend
after intervention: −0.0002). In high-income population,
prompt increase after intervention were smaller than
low-income population, but trend after intervention
was increasing but it was not statistically significant
(Intervention: 0.0014; trend after intervention: 0.0004).
In dyspepsia, monthly outpatient visits were decreased
after the intervention in both sub-population, but only
trend after intervention were statistically significant (Trend
after intervention: −0.0066(low-income), −0.0078(high-in-
come)). For migraine, there were prompt decrease in
low-income population after the intervention and it
was statistically significant (Intervention: −0.0801).
Trend after intervention was increasing but it was not
statistically significant. In high-income population,
nothing was statistically significant.
Figure 1 presents the unadjusted graph of outpatient
visits for acute upper respiratory infections. Notably,
the number of visits showed a decreasing trend before
the intervention, but implementation of the policy led
to a prompt increase in the number of visits. Figure 2
presents the unadjusted graph of outpatient visits for
dyspepsia symptoms. Before the intervention, the num-
ber of outpatient visits showed an increasing trend.
However, it began to noticeably decrease after imple-
mentation of the over-the-counter medication policy.
Finally, Fig. 3 presents the number of outpatient visits
for migraine. Although implementing the policy ap-
pears to have led to a prompt decrease in the number
of visits, this number there after appeared to increase
somewhat sharply. Figures 4, 5, 6, 7, 8, 9 presents the
number of outpatient visits for acute upper respiratory in-
fections, dyspepsia, and migraine among sub-population
divided by income. Prompt effect of the policy was
Table 4 Interrupted time series analysis of the effect of the over-the-counter drug policy on number of monthly outpatient visits for
acute upper respiratory infections, dyspepsia, and migraine (Low-income patients)
Acute upper respiratory infections Dyspepsia Migraine
Estimation Standard error p-value Estimation Standard error p-value Estimation Standard error p-value
Trend −0.0003* 0.0001 <.0001 0.0102* 0.0008 <.0001 0.0067* 0.0006 <.0001
Intervention
Yes 0.0052 0.003 0.0854 −0.0488 0.0307 0.1114 −0.0801* 0.0241 0.0009
No Ref. - - Ref. - - Ref. - -
Trend after intervention −0.0002 0.0003 0.5126 −0.0066* 0.0032 0.0398 0.0039 0.0025 0.1256
*: p-value < 0.05; All covariates are adjusted
Table 5 Interrupted time series analysis of the effect of the over-the-counter drug policy on number of monthly outpatient visits for
acute upper respiratory infections, dyspepsia, and migraine (High-income patients)
Acute upper respiratory infections Dyspepsia Migraine
Estimation Standard error p-value Estimation Standard error p-value Estimation Standard error p-value
Trend −0.0003* 0.0001 <.0001 0.0102* 0.0006 <.0001 0.0053* 0.0004 <.0001
Intervention
Yes 0.0014 0.0021 0.4997 −0.0083 0.0248 0.7362 0.001 0.0199 0.9614
No Ref. - - Ref. - - Ref. - -
Trend after intervention 0.0004 0.0002 0.0824 −0.0078* 0.0027 0.0036 −0.0005 0.0023 0.8152
*: p-value < 0.05; All covariates are adjusted
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different between high-income population and low-
income population, but the trend after intervention in
prompt change after the policy, but the slope after inter-
vention were similar in all sub-population.
Discussion
Utility is a general concept for measuring the value that
individuals attach to the outcomes of various courses of
action [22]. The population of the Republic of Korea
demanded medical accessibility, and the government
agreed that such accessibility had more value than
others. As result, the policy permitting the sale of over-
the-counter drugs at places outside the pharmacy was
implemented. However, we must consider the tradeoffs
of implementing this policy.
As noted in the Introduction, over-the-counter drugs
have been studied in some detail. Qato et al. showed
how, in the United States, there was a slight decrease in
the prevalence of using over-the-counter drugsbetw-
een2005 and2011;even so, over 35% of the entire nation’s
population still used these drugs in 2011 [23]. The high
usage of over-the-counter drugs has led to identification
of the myriad side effects of such drugs. For instance,
Kogan et al. found that53.7% of sampled 3-year-old
Fig. 1 Unadjusted graph of outpatient visits for acute upper respiratory infections
Fig. 2 Unadjusted graph of outpatient visits for dyspepsia symptoms
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children had been given over-the-counter drugs that
they should not have in the past 30 days [24]. Aside
from the problem of misusing over-the-counter drugs,
there is the problem of their being abused. According to
Wazaify et al., “misuse” is defined as using an over-the-
counter drug for an appropriate medical reason but in
wrong doses or for a longer period than recommended
[25]. In contrast, “abuse” is defined as using an over-the-
counter drug for non-medical reasons such as losing
weight or getting high. In Wazaify et al., almost 85% of
participants thought that over-the-counter drugs could
be abused.
Despite the potential adverse effects, misuse, and
abuse of over-the-counter drugs, a policy permitting
the sale such drugs at places outside of pharmacies
would enable greater accessibility to medical treatment
for low-severity diseases or symptoms. The goal of the
present study was to evaluate the effect of this accessi-
bility on outpatient visits. We found that acute upper
respiratory infections had the most outpatient visits of
any of the other conditions assessed. However, the
over-the-counter drug policy did not significantly influ-
ence the number of visits for acute upper respiratory
infections, and although the trend in outpatient visits
Fig. 3 Unadjusted graph of outpatient visits for migraine
Fig. 4 Unadjusted graph of outpatient visits for acute upper respiratory infections (low-income patients)
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tended to increase after implementing the policy, it was
to a non-significant degree. One possible reason for this
is that, although accessibility to drugs had increased
after implementing the policy, the quality of medical
services may have decreased because of the lack of pre-
scriptions or physicians to provide advice on appropriate
doses and recommended lengths of use, and to check pa-
tients’ status.
In contrast, the numbers of outpatient visits for symp-
toms of dyspepsia and migraine were influenced by the
over-the-counter drug policy. As shown in Fig. 2, the
slope of monthly outpatient visits for dyspepsia indicated
an increasing trend before implementing the policy, after
which it changed to a decreasing slope; the results of the
interrupted time series analysis revealed the same trend.
For symptoms of migraine, the number of monthly out-
patient visits promptly decreased after implementing the
policy, while the trend showed no significant difference
between before and after the policy.
Overall, our findings suggest that the number of out-
patient visits for symptoms of dyspepsia and migraine
were influenced by the over-the-counter drug policy, while
the number of visits for acute upper respiratory infections
was not. However, the number of outpatient visits is but
Fig. 5 Unadjusted graph of outpatient visits for acute upper respiratory infections (high-income patients)
Fig. 6 Unadjusted graph of outpatient visits for dyspepsia symptoms (low-income patients)
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one of many ways to measure the effectiveness of the
over-the-counter drug policy. As such, our results provide
rather limited information on the overall effectiveness of
the policy. For the same reason, although the over-the-
counter drug policy did not have a dramatic effect on the
number of outpatient visits, it would be unwise to con-
clude that it is not effective. We must consider the many
other ways of measuring the effectiveness of the over-the-
counter drug policy, especially changes in patients’ quality
of life. We might, for instance, consider the sleep quality
of people suffering from the pain of dyspepsia and mi-
graine but who choose not to go to the hospital.
Bradley et al. suggested that a future trend for medica-
tion could be “self-care.” Once a physician has determined
whether long-term or recurrent treatment is required, the
treatment could be performed using over-the-counter
medications at patients’ request [26]. However, to make
such self-care work and to minimize the adverse effects,
misuse, and abuse of over-the-counter drugs, several
factors must be kept under control. First, deregulation of
over-the-counter medication should be done gradually
and carefully. In the Republic of Korea, there are 13 prod-
ucts of 4 types of medicine that have been designated as
over-the-counter drugs. Radical deregulations must be
Fig. 7 Unadjusted graph of outpatient visits for dyspepsia symptoms (high-income patients)
Fig. 8 Unadjusted graph of outpatient visits for migraine (low-income patients)
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avoided to prevent an increased incidence of side ef-
fects of over-the-counter drugs. Second, education and
labeling of over-the-counter drugs must be done prop-
erly. According to Degrootet al.’s study, mandatory la-
beling requirements have reduced the prevalence of
misuse of over-the-counter cough and cold medicine
among children 1–5 years old from 22.2% to 17.8%
[27]. Thus, we might prevent misuse of drugs for chil-
dren just by labeling them properly. Finally, collabora-
tive care is required between doctors, pharmacists, and
patients themselves [26]. Patients must know what type
and dose of over-the-counter drugs they must take,
which would require suitable education from doctors
and pharmacists.
There are some limitations to our study. First, as noted
above, this study is on how the policy influence the out-
patient number only, and no other impacts of the policy
is studied. Further studies are required such as whether
this policy induce more drug abuse and whether this
policy reduce prevalence rate of target diseases. Also,
there could be other factors influencing outpatient visits
and interact with the implementation of the policy that
we could not exclude. These confounding factors may
invalidate the attribution of changes in outpatient visits
to the policy. Second, we only have data until 2013, so
we could not determine the long-term effects of the
over-the-counter drug policy. One year after-policy
period is not long enough. Further studies are needed
after more data has been collected. Third, we did not in-
clude any socioeconomic variables other than income,
which could lead to a bias in our results. Finally, we did
not have any information about the severity of acute
upper respiratory infections, dyspepsia, or migraine, which
could have influenced the number of outpatient visits and
therefore lead to bias.
Nevertheless, our study possesses a number of strengths.
First, to our knowledge, it is the first to investigate the ac-
tual effect of the Republic of Korea’s over-the-counter
drug policy on the population using an interrupted time
series analysis. Second, because our data were sampled
from the medical record data of the entire nation, our
dataset can be nationally representative. Finally, we used a
5-year longitudinal dataset, therefore allowing for a highly
accurate analysis.
Conclusion
The deregulation of the over-the-counter drug policy re-
duced the number of monthly outpatient visits for dyspep-
sia and migraine, but not for acute upper respiratory
infections. To ensure that the over-the-counter drug pol-
icy is effective, further studies are needed and deregulation
should be performed slowly and carefully. Furthermore,
patient education and drug labeling should be done prop-
erly, and collaboration between physicians, pharmacists,
and patients is needed.
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